RT Journal Article
SR Electronic
T1 Genome-wide pleiotropy analysis identifies novel blood pressure variants and improves its polygenic risk scores
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.08.21263225
DO 10.1101/2021.09.08.21263225
A1 Zhu, Xiaofeng
A1 Zhu, Luke
A1 Wang, Heming
A1 Cooper, Richard S
A1 Chakravarti, Aravinda
YR 2021
UL http://medrxiv.org/content/early/2021/09/12/2021.09.08.21263225.abstract
AB Systolic and diastolic blood pressure (S/DBP) are highly correlated modifiable risk factors for cardiovascular disease (CVD). We report here a bidirectional Mendelian Randomization (MR) and pleiotropy analysis of systolic and diastolic blood pressure (BP) summary statistics from the UKB-ICBP BP genome-wide association study (GWAS) and construct a composite genetic risk score (GRS) by including pleiotropic variants. The composite GRS captures greater (1.11-3.26 fold) heritability for BP traits and increases (1.09- and 2.01-fold) Nagelkerke’s R2 for hypertension (HTN) and cardiovascular disease (CVD). We replicated 118 novel BP pleiotropic variants including 18 novel BP loci using summary statistics from the Million Veteran Program (MVP) study. An additional 219 novel BP signals and 40 novel loci were identified after meta-analysis of the UKB-ICBP and MVP summary statistics but without further independent replication. Our study provides further insight into BP regulation and provides a novel way to construct a GRS by including pleiotropic variants for other complex diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grant HG011052 (to XZ) from the National Human Genome Research Institute (NHGRI) and HL086694 (A.C.) from the National Heart, Lung and Blood Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Case Western Reserve University Institutional Review Board IRB number STUDY20180592.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFull summary statistics related to UKB-ICBP were obtained through request to the authors of UKB-ICBP Paul Elliott or Mark Caulfield. Summary statistics relating to the Million Veteran Program (MVP) are publically available with the accession code phs001672.v1.p1: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001672.v1.p1. The UK BioBank data are available upon application to the UKBiobank (https://www.ukbiobank.ac.uk). The coronary artery disease and myocardial infraction summary statistics can be downloaded at http://www.cardiogramplusc4d.org/data-downloads/; Stroke summary statistics can be downloaded at: http://megastroke.org/privacy.html.